Source: VIRTRIAL Blog

VIRTRIAL Blog Myasthenia Gravis: Reducing Outcome Measures Variability in Clinical Trials

June is ‘Myasthenia Gravis Awareness’ month and a great opportunity to raise awareness of this rare autoimmune disease that, like... The post Myasthenia Gravis: Reducing Outcome Measures Variability in Clinical Trials appeared first on Signant Health.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Mark S. Hanley's photo - President & CEO of VirTrial

President & CEO

Mark S. Hanley

CEO Approval Rating

90/100

Read more